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Abstract
Background: During embryogenesis the liver is derived from endodermal cells lining the digestive tract. These
endodermal progenitor cells contribute to forming the parenchyma of a number of organs including the liver and
pancreas. Early in organogenesis the fetal liver is populated by hematopoietic stem cells, the source for a number
of blood cells including nucleated erythrocytes. A comprehensive analysis of the transcriptional changes that occur
during the early stages of development to adulthood in the liver was carried out.
Results: We characterized gene expression changes in the developing mouse liver at gestational days (GD) 11.5,
12.5, 13.5, 14.5, 16.5, and 19 and in the neonate (postnatal day (PND) 7 and 32) compared to that in the adult liver
(PND67) using full-genome microarrays. The fetal liver, and to a lesser extent the neonatal liver, exhibited dramatic
differences in gene expression compared to adults. Canonical pathway analysis of the fetal liver signature
demonstrated increases in functions important in cell replication and DNA fidelity whereas most metabolic
pathways of intermediary metabolism were under expressed. Comparison of the dataset to a number of previously
published microarray datasets revealed 1) a striking similarity between the fetal liver and that of the pancreas in
both mice and humans, 2) a nucleated erythrocyte signature in the fetus and 3) under expression of most
xenobiotic metabolism genes throughout development, with the exception of a number of transporters associated
with either hematopoietic cells or cell proliferation in hepatocytes.
Conclusions: Overall, these findings reveal the complexity of gene expression changes during liver development
and maturation, and provide a foundation to predict responses to chemical and drug exposure as a function of
early life-stages.
Background
The liver is the largest internal organ and provides
many essential metabolic, exocrine and endocrine func-
tions. The use of animal models including the mouse
and primary cell cultures has identified many of the
genes and pathways regulating embryonic liver develop-
ment. These studies show that much of hepatogenesis is
conserved throughout evolution. The liver, as well as
the pancreas, develops from two unique spatial domains
of the definitive endodermal epithelium of the
embryonic foregut. Fate-mapping experiments have
shown that the liver arises from lateral domains of
endoderm in the developing ventral foregut as well as
from endodermal cells that track along the ventral mid-
line [1,2]. During closure of the foregut, the medial and
lateral domains come together as the hepatic endoderm
is specified. The pancreas is also induced in lateral
endodermal domains, adjacent and caudal to the lateral
liver domains, as well as in cells near the dorsal midline
of the foregut [3,4]. After the domains are specified and
initiate morphogenetic budding, the dorsal and ventral
pancreatic buds merge to create the gland. These events
occur at 8.5 days of mouse gestation (GD8.5), corre-
sponding to about 3 weeks of human gestation. Despite
differences in how the different progenitor domains are
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domains make endocrine and exocrine cells, and des-
cendants of both liver progenitor domains contribute to
differentiating liver bud cells [1,2].
Newly specified hepatic cells in embryos are referred
to as hepatoblasts which express albumin (Alb), trans-
thyretin (Ttr)a n da-fetoprotein (Afp)a ta b o u tt h e7
somite (7S) stage of mouse development (approximately
GD8.25). Hepatoblasts are bipotential; those residing
next to portal veins become bile epithelial cells that will
line the lumen of the intrahepatic bile ducts while most
of the hepatoblasts in the parenchyma differentiate into
hepatocytes. The maturation of functional hepatocytes
and the formation of a biliary network connected to the
extrahepatic bile ducts are gradual, beginning at GD13
and continuing until after birth [2].
Between GD9.5 and GD15 the liver bud undergoes
substantial growth and becomes the major site of fetal
hematopoiesis. Erythrocytes are required for survival
and growth of the mammalian embryo beyond early
post-implantation stages of development. The embryo’s
first “primitive” erythroid cells, derived from a transient
wave of committed progenitors, emerge from the yolk
sac as immature precursors and differentiate as a semi-
synchronous cohort in the bloodstream [5]. The yolk
sac also synthesizes a second transient wave of “defini-
tive” erythroid progenitors that enter the bloodstream
and seed the fetal liver. Simultaneously, hematopoietic
stem cells within the embryo also seed the liver and are
the presumed source of long-term erythroid potential.
Fetal-definitive erythroid precursors mature in macro-
phage islands within the liver, enucleate, and enter the
bloodstream as erythrocytes. Toward the end of gesta-
tion, definitive erythropoiesis shifts to its final location,
the bone marrow [6].
Fetuses and neonates are generally considered more
susceptible to xenobiotics than adults [7]. Pharmacoki-
netic differences in the fetus, newborns and children
may alter responses to environmental chemicals com-
pared to adults, potentially resulting in a different spec-
trum of susceptibility to adverse health effects.
Detoxification and elimination of xenobiotics is a major
function of the liver and is important in maintaining the
metabolic homeostasis of the organism. Xenobiotics are
metabolized by a large number of xenobiotic metaboliz-
ing enzymes and transporters which fall into three
broad categories: phase I, phase II and transporters.
Phase I enzymes are involved in oxidation, reduction,
and hydrolysis, and include cytochrome P450 family
members. Phase II enzymes convert the products of
phase I metabolism into amphiphilic anionic conjugates
that are water soluble and include glutathione trans-
ferases, UDP-glucuronyl transferases, and sulfotrans-
ferases. Phase III transporters export conjugated
xenobiotics out of the liver and include ATP binding
cassette subfamily members, organic anion and cation
transporters, and solute carriers [8]. A large number of
genetic and biochemical studies have shown that the
level of expression and activity of individual XMEs in
part determines the fate of a specific xenobiotic and
whether exposure results in toxicity [9,10]. A compre-
hensive understanding of the differences between fetal
and neonatal XME gene expression with that in the
adult would be useful to predict classes of chemicals to
which these life stages may exhibit altered responses.
Liver gene expression during development has been
examined previously. Jochheim et al. [11] studied gene
expression profiles in GD7.5, GD11.5, and GD13.5 BALB/
C mice using microarrays of ~12,000 genes. The greatest
number of differentially regulated genes (3063) was found
in GD11.5 versus adult liver, and the lowest number was
found in GD11.5 versus GD13.5 (517) [11]. Gene expres-
sion changes were observed for a number of genes known
to be involved in liver development, including Afp, Alb, C/
EBP alpha, C/EBP beta, GATA-4 and Hex. Jochheim-
Richter et al. [12] subsequently performed a cluster analy-
sis of livers from GD9.5, GD11.5, and GD13.5 BALB/C
mice. One hundred and thirty genes were continuously
expressed at all stages of development with peak expres-
sion of 44 genes at GD9.5. Li et al. [13] studied gene
expression and transcriptional regulation at 14 time points
across the C57/B6 mouse liver development, from GD11.5
to adult. Cell-cycle-related genes were highly expressed in
early embryo development, defense-related genes were
activated around birth, and liver-function-related tran-
scription factors and genes were highly activated in the
later stage of development [13].
Using full-genome arrays, we determined the tran-
scriptional ontogeny of the developing liver from
GD11.5 to the adult. We examined the expression of
genes important in liver differentiation, hematopoiesis,
and xenobiotic metabolism. Although liver gene expres-
sion during development has been examined previously,
as described above, we employed a number of strategies
to provide insights into the function of the genes identi-
fied including comparing the liver profiles to the profiles
generated from at least 100 different mouse tissues and
to those profiles that were derived from different types
of blood cells. In addition, we describe in greater detail
the relationships between the changes in those genes
involved in chemical metabolism and transport and pos-
sible phenotypic effects of chemical exposure.
Methods
Animals and study design
Study 1- samples for microarray
In Study 1, timed-pregnant C57BL/6J dams were pur-
chased from Charles River Laboratory (Raleigh, NC) and
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polycarbonate cages on Alpha-dri bedding (Shepherd
Specialty Papers, Kalamazoo, MI). Animal facilities were
controlled for temperature (20-24°C) and relative
humidity (40-60%), and kept under a 12-h light-dark
cycle. The basal diet was pellet chow (LabDiet 5001,
PMI Nutrition International LLC, Brentwood, MO) and
tap water was provided ad libitum. Pregnant dams were
sacrificed at gestational day (GD) 19 and male pups
were sacrificed by decapitation. Mice from additional lit-
ters at ages PND7, PND30, and PND67 were sacrificed
using CO2 asphyxiation. Only male mice were used in
this study. Livers were removed, weighed and sections
from the left and median lobes were fixed in formalin,
embedded, sectioned, and stained with H&E. The
remainder of the liver was cubed and stored at -80°C
until RNA isolation.
Study 2- samples for Real-Time RT-PCR
RNA samples used for real-time RT-PCR were obtained
from another study run by a collaborating author. In
Study 2, timed pregnant CD-1 mice were obtained from
Charles River Laboratories (Raleigh, NC), where females
were bred overnight, and the sperm positive females
were designated GD0. Pregnant mice were shipped to
EPA on GD0 and upon arrival were housed individually
in polypropylene cages with Alpha-dri (Shepherd Speci-
alty Papers, Kalamazoo, MI) bedding and provided pellet
chow (LabDiet 5001, PMI Nutrition International LLC,
Brentwood, MO) and tap water ad libitum.A n i m a l
facility conditions were the same as in Study 1. Pregnant
mice were killed on GD14 and GD17 for collection of
adult and fetal livers. Fetal livers were pooled by litter
because these tissues were small and determination of
sex of the fetuses was not feasible, as it would have
required extensive additional work. Remaining dams
were allowed to deliver pups and tissues were collected
from pups on PND 1, 7, 14, 21, and 28. Since fetal livers
were pooled, with male and female expected to be
represented equally for each litter, a decision was made
to also pool the postnatal livers with one male and one
female per litter combined for RNA preparation. All lit-
ters were weaned on postnatal day (PND) 21 at which
time liver was also collected from the dams. At collec-
tion, livers were frozen in RNA-Later (Ambion Inc, Aus-
tin, TX) at -80°C until RNA isolation.
All animal studies were conducted in accordance with
guidelines established by the U.S. EPA ORD/NHEERL
Institutional Animal Care and Use Committee. Proce-
dures and facilities were consistent with the recommen-
dations of the 1996 NRC “G u i d ef o rt h eC a r ea n dU s e
of Laboratory Animals”, the Animal Welfare Act, and
Public Health Service Policy on the Humane Care and
Use of Laboratory Animals.
RNA isolation
Total RNA was isolated from mouse livers using TRI
reagent (Sigma Chemical, St. Louis, MO) according to
the manufacturer’s directions, and further purified using
the Qiagen RNeasy mini RNA cleanup protocol (Qiagen,
Valencia, CA). RNA pellets were stored in 70% ethanol
at -80°C until further use. The integrity of each RNA
sample was determined using an Agilent 2100 Bioanaly-
zer (Agilent, Foster City, CA), and RNA quantity was
determined using a Nanodrop
® ND-100 (NanoDrop
Technologies, Wilmington, DE).
Microarray hybridizations
Liver gene expression analysis was performed according
to the Affymetrix recommended protocol using Affyme-
t r i xM o u s eG e n o m e430 2.0 GeneChips
® containing
probes for over 30,000 well-characterized genes. Total
RNA (5 μg per sample) was labeled using the Affyme-
trix
® One-Cycle cDNA Synthesis protocol and hybri-
dized to arrays as described by the manufacturer
(Affymetrix
®, Santa Clara, CA). Microarray hybridiza-
tions were conducted overnig h ta t4 5 ° Cw h i l er o t a t i n g
in an Affymetrix hybridization oven. After 16 hours of
hybridization, the cocktail was removed and the arrays
were washed and stained in an Affymetrix GeneChip
®
fluidics station 450 according to the Affymetrix-recom-
mended protocol. Arrays were scanned on an Affymetrix
GeneChip
® scanner. Four mice per age group (from
Study 1) were examined.
Analyses of Microarray data
All Affymetrix (Santa Clara, CA) .cel files were first ana-
lyzed by Bioconductor’s SimpleAffy package to assess
data quality [14]. All .cel files passed this QC step. Data
(.cel files) were background corrected and statistically
filtered using Rosetta Resolver
® version 7.1 software
(Rosetta Inpharmatics, Kirkland, WA). The background
correction was done by Resolver’s specific data proces-
sing pipeline (Affymetrix Rosetta-Intensity Profile
Builder). Statistically significant genes were identified
using one-way ANOVA with a false discovery rate (Ben-
jamini-Hochberg test) of ≤ 0.05 followed by a post-hoc
test (Scheffe) for significance. Hierarchical clustering
was performed using CLUSTER and visualized with
TREEVIEW [15]. A detailed description of the microar-
ray experiment is available through Gene Expression
Omnibus at the National Center for Biotechnology
Information at http://www.ncbi.nlm.nih.gov/geo/, as
accession number GSE21224.
Reanalysis of published microarray data
The raw data files analyzed in this project (.cel files
from Affymetrix DNA chips) were downloaded from
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were analyzed as described above. A detailed description
of each experiment is available through Gene Expression
Omnibus at the National Center for Biotechnology
Information at http://www.ncbi.nlm.nih.gov/geo/.
To create a broader view of gene expression changes
during development, we combined our dataset from the
GD19 - PND67 male C57BL/6 mice with a dataset from
CD-1 mice at GD11.5, GD12.5, GD13.5, GD14.5 and
GD16.5 in which 10-week-old females were used as con-
trols ([16]; GDS2577). Given differences in the experi-
ments, we used Distance Weighted Discrimination
(DWD) [17] to minimize systematic microarray data
biases attributable to RNA source, different analysis
laboratories, different microarrays, or other systematic
differences which include sex and strain in this case.
DWD applies Singular Value Decomposition amended
with Fisher Linear Discrimination to find better correc-
tions for systematic effect adjustments. These adjust-
ments were applied to preserve variation not caused by
systematic effects. Based on evaluation of Affymetrix
spike-in controls, the samples from the two experiments
exhibited similar behavior by PCA after the procedures
were applied (Additional File 1). The resulting merged
dataset was used for global analysis of fetal and neonatal
expression as well as the analysis of pancreas-specific
genes, hematopoietic-specific genes and xenobiotic
metabolism genes. In this merged dataset, the fetal and
neonatal samples were normalized to the adult samples
from the two studies. The data was also analyzed by
TightCluster, a resampling-based approach for identify-
ing stable and tight patterns in data [18]. We used only
the GD19 - PND67 dataset generated from male
C57BL/6J mice (Study 1) to perform the analysis of the
time course of pancreas-specific genes. In this case the
DWD was not applied, but rather we used the Rosetta
Resolver procedures as detailed above. The fetal (GD19)
and neonatal (PND7, PND30) samples were compared
to the PND67 adult samples.
Genes were divided into those that were up- or down-
regulated and were analyzed separately for enrichment
of canonical and toxicity pathways using Ingenuity Path-
way Analysis (IPA). Pathways that did not meet the p-
value significance (p ≥ 0.05) were excluded. P-values
were converted to -Log(p-value). For those significant
pathways derived from down-regulated genes all -Log(p-
value)s were converted to negative numbers. All data
was clustered and visualized as described above using
Cluster and TreeView.
The microarray data from the liver samples were com-
pared to a database of > 80 other mouse tissues (GNF
Mouse GeneAtlas V3; GEO ID GSE10246). Compari-
sons were made in Rosetta Resolver using PCA of all
tissues and hierarchical clustering comparing the liver
and pancreas samples. Tissue-specific signature genes
were generated from this dataset by identifying those
genes which exhibited differential expression between
either 1) the top 1000 adult pancreas genes (p < 3.16E-
05), 2) the top 500 fetal liver genes (p < 2.55E-08), or 3)
the top 500 bone marrow genes (p < 3.07E-04) and all
other tissues in the dataset.
Human samples were derived from the following
ArrayExpress submissions: E-TABM-185, E-AFMX-5, E-
MTAB-24, and E-MTAB-25. They included 3 fetal
livers, 10 adult livers and 5 adult pancreases. Hierarchi-
cal clustering was performed in Rosetta Resolver.
Mouse-human comparisons of canonical pathways were
made using IPA as described above. Genes were divided
into those 1) expressed in fetal liver only, 2) common to
pancreas and fetal liver with the fetal liver fold-change
values and 3) in pancreas only. These 3 groups were
analyzed using IPA before and after separation into up-
and down-regulated genes. The same canonical path-
ways were compared between mice and humans.
We examined the expression of genes identified as sig-
nature genes for purified erythropoeitic cells including
natural killer (NK) cells, T cells, B cells, monocytes,
neutrophils, nucleated erythrocytes, and activated and
naive CD4+ (helper) and CD8+ (cytotoxic) T cell sub-
sets ([19]; GSE6506). The signature genes were derived
from the Chambers et al. [16] study.
Evaluation of selected genes by Real-Time RT-PCR
Expression of 10 genes (A2m, Afp, Hamp2, Reep5,
Slc39a5, Spink3, Alas2, Epor, Gata1, Klf1) was con-
firmed using the tissues from Study 2 by quantitative
RT-PCR, validating our microarray analysis procedures.
Quantitative RT-PCR was performed on RNA from the
eight age groups (2 prenatal, 5 postnatal, and 1 adult
age group with four samples per group) in Study 2
(described above). Eighty-five nanograms of total RNA
were loaded into each one-step qRT-PCR reaction con-
taining 1X QuantiTect™ Probe RT-PCR master mix
(Qiagen, Valencia, CA) and 1 × TaqMan
® Gene Expres-
sion Assays (Applied Biosystems, Foster City, CA) for
the desired gene target. We examined the expression of
two housekeeping genes (Actb, Gapdh)t h r o u g h o u t
d e v e l o p m e n ta n ds h o w e dt h a te x p r e s s i o nc h a n g e ds i g -
nificantly with greatest expression for both genes
between GD14 and GD17, indicating that these genes
were not appropriate normalization controls (Additional
File 2). Therefore, a relative standard curve was gener-
ated for each target using serially diluted RNA pooled
from the study. Relative quantities were calculated from
the appropriate relative standard curve. Relative quanti-
ties were then compared among treatment groups. Sta-
tistical significance was determined using Tukey-Kramer
HSD.
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Embryos were fixed in 4% paraformaldehyde and
embedded in paraffin. Sections were cut, deparaffinized,
treated with proteinase K (10 ug/mL) for 10 minutes,
post-fixed with 4% paraformaldehyde and acetylated
with triethanolamine buffer (pH 8.0) containing 0.25%
acetic anhydride for 10 minutes. After rinsing, slides
were hybridized with antisense and sense DIG-labeled
RNA probes. Probes were 600-700bp PCR products
amplified from embryonic liver cDNA libraries using
gene specific primers. Gel-purified PCR products were
subcloned and labeled using a DIG RNA-labeling mix
(Roche Applied Science, India n a p o l i s ,I N ) .S l i d e sw e r e
hybridized with labeled sense and anti-sense probes in
50% formamide, 10% dextran sulfate, 1x Denhardt’s
solution, 200ug/mL tRNA, 10mM Tris pH 7.5, 600mM
NaCl, 1mM EDTA, 0.25% SDS in a humidified chamber
overnight at 65 degrees C. Slides were washed in 5X
SSC, 2X SSC and 0.2X SSC at 50 degrees C. DIG was
detected with an alkaline-phosphatase-conjugated anti-
body (Roche Applied Sciences) and nitroblue tetrazo-
lium chloride-5-bromo-4-chloro-3-indoylphosphate
toludidine salt.
Results and Discussion
Transcriptional ontogeny of the developing mouse liver
Gene expression was measured in the livers from fetuses
(gestation day (GD) 11.5-19) and neonates (postnatal
day (PND) 7 and 30) and compared to that in adult
livers. Marker genes for the fetal liver were examined
for predicted expression behavior. Fetal liver-specific
genes which exhibited significant differences (p < 2.55E-
08) between fetal liver and ~80 other mouse tissues
were initially examined for changes. Figure 1A shows a
subset of the genes which exhibited increased expression
in the fetal liver compared to the adult. The genes
included alpha fetoprotein (Afp), widely recognized as a
fetal liver protein [20], a number of fetal hemoglobin
genes (hemoglobin Y, beta-like embryonic chain; hemo-
globin X, alpha-like embryonic chain in Hba complex;
hemoglobin Z, beta-like embryonic chain)a n da l p h a - 2 -
macroglobulin (A2m), known to be expressed in the
fetal liver [21]. Genes not previously associated with
fetal expression were also identified including stefin
family members (stefin A1/A3 and stefin A2 like 1)c o n -
taining cysteine protease inhibitor domains, hypoxia
inducible factor 3, alpha subunit (Hif3a)a n dt h ezinc
transporter solute carrier family 39 (metal ion transpor-
ter), member 5 (Slc39a5). The fetal expression of Afp
and A2m (Figure 1B) and Slc39a5 (discussed below) was
confirmed by RT-PCR using an independent set of livers
from fetal and neonatal mice. Genes that were down-
regulated specifically in the fetal liver were also identi-
fied (Additional File 3). Expression of the E3 ubiquitin
ligase Makorin (Mkrn1) and a regulator of splicing, Reg-
ulator of differentiation 1 (Rod1) was examined by in
situ hybridization (ISH). By microarray, both genes
exhibited maximal expression at GD14.5 (Additional
File 4, Figure S1). Expression of the genes in the liver by
ISH could be detected as early as GD10.5 through
GD15.5 (Figure 1C and Additional File 4, Figures S2-
S6). Thus, the microarray results were consistent with
the analysis of RNA expression by other methods.
Transcriptional ontogeny of the developing liver was
characterized by examining the expression of all genes
that exhibited changes during development (Figure 1D
and Additional File 5). Approximately 4370 genes exhib-
ited altered expression in at least one of the time points.
A greater number of genes were under-expressed than
over-expressed relative to the adults. The gene expres-
sion differences were most striking between GD11.5-
16.5. Petkov et al. [22] also found the gene expression of
fetal hepatoblasts to differ profoundly from that of adult
Figure 1 Transcriptional ontogeny of the developing mouse
liver. A. Expression changes in fetal liver genes. Fetal liver genes
were identified as detailed in the Materials and Methods. The
intensity scale indicates fold-changes compared to the adult
controls. Red, up-regulation; green, down-regulation; black, no
change. B. RT-PCR of fetal liver gene expression in mouse livers
from GD14 to PND28. *, indicates statistical significance of
expression changes relative to PND28 (p ≤ 0.05); ML, maternal liver.
C. In situ hybridization of Makorin 1 (Mkrn1) in the GD13.5 fetus. L,
liver; Lu, lung; St, stomach; M, metanephros; SC, spinal cord. D.
Global gene expression in the developing mouse liver. Genes which
exhibited significant differences in expression compared to adult
animals were identified as detailed in the Materials and Methods.
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PND7 and PND30 time points exhibited progressively
fewer genes and in general, smaller fold-change differ-
ences compared to the adult animals. While many genes
exhibited striking differences throughout all or most
periods of development, groups of genes were identified
that were altered only during discrete windows of devel-
opment (Figure 2A). Four major groups were identified
including 639 genes whose maximal expression was
between GD11.5 and GD12.5 (early expression), 851
genes whose maximal expression was between GD14.5
and GD16.5 (middle expression), 236 genes which
exhibited sustained and approximately uniform expres-
sion throughout development (GD11.5-GD16.5; sus-
tained expression) and 1423 genes which exhibited
maximal expression in the adult (late expression).
Genes expressed early in development included those
expressed in embryonic stem (ES) cells and are involved
in tissue development including Mdk, Ptn, Hmga2, Ndn,
and Pa2g4.M i d k i n e( Mdk) and the related cytokine
pleiotrophin/heparin-binding growth-associated mole-
cule (Ptn) are essential for normal development of the
catecholamine and renin-angiotensin pathways. Mdk
regulates Ptn expression [23], and Ptn m a yb es e c r e t e d
from embryonic mesenchymal cells as a mitogen of par-
enchymal cells in the embryonic liver [24]. The high
mobility group AT-hook 2 gene (Hmga2), abundant in
ES cells is involved in transcriptional activation of cell
proliferation genes, substantially contributing to the
plasticity of ES cell chromatin and maintenance of an
undifferentiated cell state [25]. Necdin (Ndn) preferen-
tially expressed in primitive stem cells, is an important
protein in hematopoietic stem cell regulation [26]. Pro-
liferation-associated 2G4 (Pa2g4)i se x p r e s s e di nm o u s e
ES cells [27]. The entire list of genes which exhibited
expression during discrete windows of development is
found in Additional File 6.
To categorize the pathways altered during liver devel-
opment, Ingenuity Pathways Analysis (IPA) was used to
identify the canonical pathways that were significantly
altered during development. In the first analysis, the
four sets of genes which exhibited discrete windows of
expression were examined (Figure 2B). The canonical
pathways that were significantly altered were, for the
most part, unique for the early, middle or late time peri-
ods of development. Pathways altered late in the adult
were those associated with functions of the mature liver
including intermediary metabolism, whereas almost all
of the pathways altered in the fetus were associated with
signaling pathways that control cell proliferation, active
during the growth of the liver bud.
To assess the impact of liver development on putative
pathway activation or suppression, IPA was again used
to identify pathways significantly altered at each time
point in development using those genes described in
Figure 1D. The genes at each time point were separated
into those that were up- or down-regulated relative to
the adult and were analyzed separately as detailed in the
Materials and Methods. Pathways regulated in the fetus
were dominated by those that were less active than in
the adult including those involved in intermediary and
xenobiotic metabolism, whereas putative activated path-
ways were dominated by those involved in cell prolifera-
tion and cell signaling (Figure 2C). Activated pathways
Figure 2 Canonical pathways altered in the developing liver.A .
TightCluster groups genes into 4 temporal categories during liver
development. Shown are examples of clusters that group genes
into one of the 4 temporal categories. B. Genes expressed at
different times during development fall into unique canonical
pathways. Genes in the 4 temporal groups identified using
TightCluster (Figure 2A) were analyzed using IPA. Only the top 10
significant pathways in the late group are shown. C. Global view of
canonical pathways altered during development. Canonical
pathways significantly altered at the indicated times during
development compared to adult mice were identified using IPA. D.
Increased expression of genes in canonical pathways involved in
DNA maintenance and cell cycle (top) and cell fate signaling
(bottom). E. Changes in canonical pathways of intermediary
metabolism. Left, all significantly altered pathways of metabolism.
Right, up-regulated pathways. For B-E, the scale numbers are the
-log(p-value) and range from < 10
-10 to not significant (NS). Yellow,
altered pathway using all genes as input; red, up-regulated pathway
using all up-regulated genes as input; green, down-regulated
pathway using all down-regulated genes as input; black, not
significant.
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cell cycle (G1/S checkpoint regulation, cell cycle G2/M
DNA damage checkpoint regulation, role of CHK pro-
teins in cell cycle checkpoint control, nucleotide exci-
sion repair pathway) (Figure 2D, top). Li et al. [13] also
found that in early embryo development, cell-cycle-
related genes were highly expressed and defense-related
genes were activated around birth. Pathways with well-
known effects on cell proliferation and apoptosis were
significantly regulated including those under control of
14-3-3 regulatory proteins, p53, polo-like kinase, BTG
family members, BRCA1, ATM, and OCT4 (Figure 2D,
bottom and Additional File 7). A number of liver toxi-
city pathways were also significantly modified including
increases in liver hematopoiesis (discussed below) and
hemorrhaging and down-regulation of liver cholestasis
associated with bile acid homeostasis (Additional File 8).
An examination of pathways involved in xenobiotic and
intermediary metabolism (Figure 2E) showed that while
most pathways were suppressed during development,
nine were up-regulated, the most prominent of those
being purine and pyrimidine metabolism, likely activated
to support DNA and RNA synthesis during active liver
growth (Additional File 9, Figures S7 and S8).
This analysis highlights the dramatic changes the fetal
liver undergoes during development. We identified key
pathways that support the growth and function of the
developing liver. These gene expression and pathway
changes will be a useful resource for hypothesis genera-
tion and testing of the role of genes, pathways and
genetic networks in liver development.
Transcriptional similarities between the developing liver
and the pancreas
Given that hematopoiesis is carried out in the fetal liver
[28], the extent of the transcriptional similarities were
determined between the developing liver and other tis-
sues including those involved in hematopoiesis in the
adult mouse. We performed an unsupervised compari-
son by principal components analysis (PCA) between
the developing liver and a database of > 80 other mouse
tissues which included many involved in hematopoiesis.
The fetal and neonatal samples progressed along a tra-
jectory from embryonic stem cells (i.e., Bruce4 and V26
cell lines) to the adult liver (Figure 3A). In contrast to
the prediction of similarity to hematopoietic tissues,
GD19 samples were more similar to the pancreas from
G D 1 8 . 5a n dP N D 6 0m i c et h a nt oo t h e rt i s s u e s .H i e r -
archical clustering of the liver and pancreas samples
showed that the fetal liver exhibited greater similarity to
the pancreas than neonatal and adult liver (Figure 3B).
A direct comparison of the genes altered between the
fetal vs. adult livers and the adult pancreas vs. the adult
liver demonstrated the impressive overlap in gene
expression (Figure 3C). The concordance of the overlap-
ping genes was striking both in direction of change and
intensity of the differences (Figure 3D). Pancreas-specific
genes (p < 3.16E-05) were identified as detailed in the
Materials and Methods and examined for expression
changes throughout development (Figure 3E). The genes
included many that were up-regulated and not pre-
viously associated with the fetal liver. The pancreas-spe-
cific genes that were expressed in the fetal liver did not
include those that are islet-specific (e.g., islet amyloid
polypeptide (Iapp), insulin I (Ins1), insulin II (Ins2), and
regenerating islet-derived genes (Reg1, Reg2, Reg3a,
Reg3b)).
To determine the prevalence of expression of pan-
creas-related genes in the late term fetus and in the
neonate, we examined expression in the livers from
male mice at GD19, PND7, PND30 compared to
PND67. Many of the up-regulated genes exhibited sus-
tained expression through PND7 including Reep5,
Spink3 and Slc39a5 (Figure 3F). In contrast, many genes
encoding digestive enzymes secreted by pancreatic aci-
nar cells were down-regulated in the fetal and neonatal
livers including carboxypeptidase A2, pancreatic (Cpa2),
elastase 3, pancreatic (Ela3), carboxypeptidase B1 (tis-
sue) (Cpb1), and colipase, pancreatic (Clps).
Expression of four pancreas-specific genes (Hamp2,
Reep5, Slc39a5, Spink3) was examined by RT-PCR (Fig-
ure 3G). Reep5, Slc39a5 and Spink3 exhibited peak
expression between GD14 and GD17 whereas Hamp2
was suppressed until PND14. None of these genes
appear to have been previously associated with expres-
sion in the fetal liver, whereas there is ample evidence
for expression in the fetal or adult pancreas. Hepcidin
antimicrobial peptide 2 (Hamp2) is responsive to dietary
iron, indicating a role for Hamp2 in the regulation of
iron homeostasis [29]. Hamp2 expression is sex-depen-
dent, with higher expression in female mouse livers [30],
consistent with the higher expression in the maternal
liver than in the adult male liver (Figure 3G). Receptor
accessory protein 5 (Reep5), also known as deleted in
polyposis 1 (Dp1), is an integral membrane protein that
may be involved in shaping the tubular ER [31]. Solute
carrier family 39 (metal ion transporter), member 5
(Slc39a5)( a l s ok n o w na sZip5) belongs to a subfamily
of proteins that show structural characteristics of zinc
transporters. Slc39a5 expression is restricted to many
tissues important for zinc homeostasis, including the
intestine, pancreas, liver and kidney and localizes to the
basolateral surfaces of pancreas acinar and intestinal
enterocyte cells in mice fed a zinc-adequate diet. This
protein is removed from these cell surfaces and interna-
lized during dietary zinc deficiency, indicating that
Slc39a5 functions to remove zinc from the blood via the
pancreas and intestine, the major sites of zinc excretion
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http://www.biomedcentral.com/1471-2164/13/33
Page 7 of 16Figure 3 Transcriptional similarities between the fetal liver and pancreas in the mouse. A. Principal component analysis (PCA) of fetal and
neonatal liver compared to a library of ~80 mouse tissues. Left, view of all mouse tissues used in the comparison. Right, enhanced view
showing the trajectory of liver maturation (arrow) from stem cells to adult livers and similarity between GD19 livers and pancreas from GD18.5
and adult animals. B. Fetal liver exhibits greater similarity to pancreas than adult liver. The biological replicates were clustered using hierarchical
clustering. C. Overlap in the genes differentially expressed in the fetal liver or pancreas compared to the adult liver. Fetal liver (GD19) or adult
pancreas (PND60) was compared to adult livers. D.Concordance in the direction and intensity of the fold-changes in the 9919 overlapping genes
from C. E. Expression of pancreas-specific genes in the developing liver. Left, expression of all genes identified as detailed in the Materials and
Methods. The position of Hamp2, examined by RT-PCR is shown. Right, pancreas-specific genes up-regulated during development. Arrowheads
indicate genes examined by RT-PCR. F. Sustained expression of a subset of pancreas-specific genes in the neonate. The expression of the
pancreas-specific genes was examined in the C57BL/6J male mice at the indicated times in the fetus and neonate. For D-F, the intensity scale
indicates fold-changes compared to the adult controls. Red, up-regulation; green, down-regulation; black, no change. G. RT-PCR of pancreas-
specific gene expression in mouse livers from GD14 to PND28.
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Page 8 of 16in mammals [32]. The serine peptidase inhibitor, Kazal
type 3 (Spink3), is a trypsin inhibitor, secreted from pan-
creatic acinar cells into pancreatic juice. Spink3 can be
detected in the pancreas at GD11.5, before formation of
the typical shape of the exocrine structure of the pan-
creas; acinar cell expression is clearly identified by
GD13.5 [33]. Spink3 protein may function to prevent
trypsin-catalyzed premature activation of zymogens
within the pancreas and the pancreatic duct. Mutations
in this gene are associated with hereditary pancreatitis.
In Spink3-null mice, the pancreas develops normally up
to GD15.5, and starting at GD16.5, there is evidence of
autophagic degeneration of acinar cells, but not ductal
or islet cells, indicating that Spink3 has essential roles in
the integrity of pancreatic acinar cells [34]. Spink3 is
induced in the pancreas after pancreatic injury and its
up-regulation may reflect an important endogenous
cytoprotective mechanism to prevent further injury [35].
Both Spink3 and Reep5 are enriched in pancreatic cells
over-expressing the pancreatic transcription factor gene
pancreatic-duodenal homeobox 1 (Pdx1) [36]. Additional
genes known to be expressed in the pancreas and identi-
fied in our study included Pdia2 also known as protein
disulfide isomerase (pancreas) like [37], phosphoenolpyr-
uvate carboxykinase 2 (mitochondrial) (Pck2) [38] and
phosphoglycerate dehydrogenase (Phgdh) [39].
To determine if the human fetal liver also exhibits a
pancreas-like signature, a number of human samples
were examined from an archived tissue set (Figure 4A).
The three fetal liver samples exhibited greater similarity
with five adult pancreas samples than with the majority
of the adult liver samples. Similar to the mouse results,
a direct comparison of the genes which were altered
between the fetal vs. adult livers and the adult pancreas
vs. the adult liver also showed extensive overlap in
humans (Figure 4B), including concordance of the over-
lapping genes in direction of change and intensity of the
differences (Figure 4C).
We next asked whether the pancreas-related genes
found in the fetal liver exhibited functional overlap in
mice and humans. IPA was used to identify the canoni-
cal pathways that were overrepresented by the 3 groups
of genes in mice and humans identified in Figures 3C
and 4B, respectively. The pathways altered in each spe-
cies were then compared directly. A number of path-
ways exhibited similar representation in both mice and
humans. The greatest overlap in the up-regulated path-
ways included those involved in cell proliferation (Cell
Cycle: G2/M DNA Damage Checkpoint Regulation, Role
of CHK Proteins in Cell Cycle Checkpoint Control,
Molecular Mechanisms of Cancer, Role of BRCA1 in
DNA Damage Response, and Cell Cycle: G1/S Check-
point Regulation). These pathways were significantly
altered in the fetal liver only, as well as the common
genes in both species. In humans and to a lesser extent
mice, these pathways were more significant in the fetal
liver as expected given the higher level of cell prolifera-
tion compared to the adult pancreas. The greatest over-
lap in the down-regulated pathways included those
involved in lipid and steroid homeostasis, and stress
responses (Protein Ubiquitination Pathway, NRF2-
mediated Oxidative Stress Response, PPARa/RXRa
Activation, LPS/IL-1 Mediated Inhibition of RXR Func-
tion, Biosynthesis of Steroids, Angiopoietin Signaling,
Butanoate Metabolism, LXR/RXR Activation, TR/RXR
Activation). These pathways were generally altered in
common and pancreas-only gene sets in both species.
These results indicate that the developing liver in mice
and humans exhibits transcriptional features similar to
the adult pancreas. The fact that genes related to pan-
creas function are expressed in the neonatal liver is
intriguing and prompts the question of whether there is
a functional significance to the overlap in the expression
of pancreas-specific genes in the neonate. The expres-
sion of the pancreas-specific genes in the fetus and neo-
nate does not include those genes encoding pancreatic
digestive enzymes from the acinar cells or those
Figure 4 Transcriptional similarities between the fetal liver and
pancreas in humans. A. Fetal liver exhibits greater similarity to
pancreas than adult liver in humans. The biological replicates were
clustered using hierarchical clustering. B. Overlap in the genes
differentially expressed in the fetal liver or pancreas compared to
the adult liver. C. Concordance in the direction and intensity of the
fold-changes in the 1271 human overlapping genes from B. The
intensity scale indicates fold-changes compared to the adult livers.
Red, up-regulation; green, down-regulation. D. Common canonical
pathways in mice and humans that are altered in fetal liver and
pancreas compared to adult liver. Genes were divided into those
depicted in the Venn diagrams in Figure 3C and Figure 4B as 1)
expressed in fetal liver only, 2) common to pancreas and fetal liver
and 3) in pancreas only. These 3 groups were analyzed using IPA
before and after separation into up- and down-regulated genes. The
same canonical pathways were compared between mice and
humans. The scale is described in Figure 2 legend.
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Page 9 of 16associated with the islet cells. Thus, the analysis indi-
cates that the fetal and to a lesser extent the neonatal
liver exhibits some transcriptional features of the adult
pancreas which may reflect the common embryonic ori-
gins of these tissues but not necessarily the inherent
functions of the pancreas.
Identification of a nucleated erythrocyte-specific gene
expression signature in the developing liver
The developing liver is a major source of fetal hemato-
poiesis. A comprehensive identification of liver versus
hematopoietic-specific genes during development would
be useful to dissect transient or sustained roles for
genes in mediating chemical induced effects in the fetal
liver. We focused on distinguishing between gene
expression changes due to the resident cells of the liver
and hematopoietic cells that are transiently present in
the fetal liver. Given that many types of blood cells are
produced in the bone marrow, adult bone marrow-spe-
cific genes (top 500 genes, p < 0.00031) were first identi-
fied and then examined for expression changes in the
developing liver (Figure 5A, left). These genes uniformly
exhibited increased expression compared to adult mice
that peaked between GD13.5 and GD16.5. Only a hand-
ful of these genes retained elevated expression past
GD19, consistent with hematopoietic stem cells migrat-
ing from the liver to populate other tissues after birth.
Many of the genes possess functions associated with
erythrocytes including heme biosynthesis and iron trans-
port (Figure 5A, right).
The individual signatures of specific blood cell types
in the fetal liver were examined using marker genes for
10 different blood cell types or categories [19]. Out of
the 1418 signature genes for the different blood cell
types, a total of 117 genes overlapped with those regu-
lated in the fetal liver. The genes were enriched for
nucleated erythrocytes (29 expected but 59 observed)
whereas all other cell types except hematopoietic stem
cells had less than expected numbers of genes (Figure
5B). Most of the nucleated erythrocyte signature genes
exhibited increased expression compared to adult con-
trols (Figure 5C) whereas the hematopoietic stem cell
signature genes and genes for other cell types (Addi-
tional File 10) were dominated by down-regulated genes.
The expression of four genes (Alas2, Epor, Gata1,
Klf1) identified as bone-marrow or nucleated erythro-
cyte-specific were confirmed by RT-PCR. All four genes
exhibited similar changes during development that were
different from the pancreas-specific genes with peak
expression at the earliest measured time (GD14) and
decreasing expression until PND14, at which time
expression was low or not detectable (Figure 5D).
GATA binding protein 1 (globin transcription factor 1;
Gata1) is a transcription factor that plays an important
role in erythroid development by regulating the switch
of fetal hemoglobin to adult hemoglobin. The Kruppel-
like factor 1 (erythroid) (Klf1 or Eklf1) encodes a hema-
topoietic-specific transcription factor that induces high-
level expression of adult beta-globin and other erythroid
genes. Aminolevulinic acid synthase 2, erythroid (Alas2)
specifies an erythroid-specific mitochondrially located
enzyme. The encoded protein catalyzes the first step in
the heme biosynthetic pathway. Drug-induced hemolytic
anemia can be detected based on hepatic changes in the
expression of genes including Alas2 that are mechanisti-
cally linked to hematotoxicity [40]. The erythropoietin
receptor (Epor) is a member of the cytokine receptor
Figure 5 Identification of a nucleated erythrocyte-specific gene
signature in the developing liver. A. Expression of bone marrow-
specific genes in the fetal liver. Left, bone marrow-specific genes
identified in the GNF Mouse GeneAtlas V3 dataset were queried for
changes in the fetal/neonatal dataset. Right, bone marrow-specific
genes expressed in the fetal liver with erythrocyte-associated
functions in iron transport and hemoglobin synthesis. Genes
confirmed by RT-PCR are indicated. B. Alteration in the signature
genes for different blood cell types in the developing liver. The
percentage of genes that were altered in each of the groups out of
the total number of genes was compared across all of the time
points. The values were compared to the expected contribution
from each of the cell types based on percentage of total number of
genes (right column). The figure shows the greater than expected
contribution of the nucleated erythrocyte signature genes to the
overall pattern. Changes in the genes for the following cell types or
categories were not observed: Differentiated cells, Lymphocytes,
Monocytes, Naïve T-cells. The scale represents the percentage of
genes from the indicated cell type to the overall gene expression
pattern. C. Expression of nucleated erythrocyte-specific genes in the
fetal liver. Nucleated erythrocyte-specific genes [16] were examined
for expression changes in the fetal/neonatal dataset. Genes
confirmed by RT-PCR are indicated. D. RT-PCR confirmation of
nucleated erythrocyte-specific gene expression in livers from GD14
to PND28.
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Page 10 of 16family. Upon erythropoietin binding, EpoR activates a
kinase-mediated cascade culminating in the activation of
erythrocyte-specific transcription factors including
Gata1 [41]. A functional Epor is likely necessary and suf-
ficient for thrombopoietin to exert its mitogenic effects
on erythroid cells [42] and appears to have a role in ery-
throid cell survival [43]. EpoR with common beta recep-
tor (BetacR) comprise a tissue-protective heteroreceptor
that mediates the tissue-protective effects of erythro-
poietin in preclinical models of ischemic, traumatic,
toxic, and inflammatory injuries [44].
The results demonstrate that signature genes for
nucleated erythrocytes can be identified within the
developing liver and indicate that nucleated erythrocytes
exhibit the dominant hematopoietic cell transcriptional
signature in the developing liver. Gene and protein
expression analysis of a more limited set of tissues dur-
ing mouse liver development also uncovered features of
hematopoiesis in the developing liver [45], and in gen-
eral their findings are consistent with ours. However,
the results from our study indicated that many markers
for hematopoiesis were elevated past the latest time
point in the Guo et al. study (PND3). Li et al. [13] also
examined gene expression at 14 time points across the
C57/B6 mouse liver development, and found the gene
expression of markers for hematopoiesis peaked from
GD12.5 to GD17.5 and then decreased at GD18.5 and
older. Our studies provide a foundation on which to
examine the effects of different genetic and environmen-
tal effects on these genes and their down-stream
consequences.
Impact of development on xenobiotic metabolism gene
expression
The fetus and neonate are considered potentially sensi-
tive populations to the adverse effects of environmen-
tally relevant chemicals. We were interested, therefore,
in characterizing the expression of genes that impact
xenobiotic metabolism which may allow follow-on pre-
dictions of chemicals to which the fetus or the neonate
may be particularly sensitive [46]. We examined canoni-
cal pathways involved in xenobiotic metabolism includ-
ing those controlled by nuclear receptors. Most
pathways were down-regulated throughout development
(Figure 6A). Aryl hydrocarbon receptor (AhR) signaling
was represented by both up- and down-regulated genes,
possibly due to the dual role of AhR in liver vasculariza-
tion during development and xenobiotic metabolism in
the adult liver in different cell types [47].
The xenobiotic metabolism genes were separated into
phase I cytochrome P450 Cyp genes, phase II conjuga-
tion enzymes and phase III transporter genes. Remark-
ably, all Cyp genes (Figure 6B) and most phase II genes
(Figure 6C) were under expressed relative to the adult
animals. Only the phase II genes, Mgst3 and Gstm5,
exhibited increased expression through development.
Under expressed genes exhibited discrete times at which
they achieved adult expression levels with a few genes
achieving adult levels as early as GD14.5 (Cyp7a1,
Cyp4f13, Gstt2, Gstm3, Ugt2b34, Sult1d1). Most genes
achieved adult expression levels after GD16.5. However,
even at PND7, the expression of many genes was lower
than those in adults.
While genes involved in transport were generally
under expressed during development, there were 21
genes which exhibited increased expression. Expression
of a number of these phase III genes overlapped with
the signature genes for nucleated erythrocytes
(Slc25a10, Slc38a5, Slc43a1, Abcb10, Slc25a38) [19] or
pancreas (Slc39a5) (Figure 6D). Transporters with
increased fetal expression included genes with known
endogenous functions such as transport of amino acids
(S l c 1 a 5 ,S l c 3 8 a 1 ,S l c 3 8 a 5 ,S l c 3 a 2 ,S l c 4 3 a 1 ,S l c 6 a 9 ,
Slc7a1, Slc7a5), adenine nucleotide (Slc25a4), glucose
(Slc2a1, Slc2a3), heme (Abcb10, Slc25a37, Slc25a38,a l l
found on the inner mitochondrial membrane), inorganic
anion (Slc4a1(erythrocyte membrane protein band 3,
Diego blood group)), inorganic phosphate (Slc20a1),
monocarboxylic acids such as lactate (Slc16a1), urea
(Slc14a1), and zinc (Slc39a5, Slc39a8). The expression
changes for ~40 xenobiotic metabolizing genes in phase
I, II and III at GD19-PND67 were confirmed and are
published elsewhere [46].
A number of the phase III genes that are coordinately
up-regulated during development may have essential
roles in liver growth. The amino acid transporters
Slc1a5, Slc7a5 and Slc3a2 play roles in regulating the
target of rapamycin complex 1 (TORC1), a highly con-
served serine/threonine kinase that in mammals acti-
vates cell growth in response to stimuli including
nutrients (amino acids), growth factors (such as insulin
and insulin-like growth factor), and cellular energy sta-
tus (ATP). Inhibition of TORC1 activates autophagy
[48]. The mammalian target of rapamycin (mTOR)
canonical pathway was significantly altered during early
(p = 2.16E-05) and mid (p = 4.79E-02) expression peri-
ods of liver growth (Figure 2A). L-glutamine uptake is
regulated by Slc1a5 and loss of Slc1a5 function inhibits
cell growth and activates autophagy. The complex of
Slc7a5/Slc3a2, acts as a bidirectional transporter that
regulates the simultaneous efflux of L-glutamine out of
cells and transport of L-leucine/essential amino acids
into cells. Thus, L-glutamine flux regulates mTOR to
coordinate cell growth and proliferation [49]. In addition
to the role of Slc1a5/Slc7a5/Slc3a2 in liver growth,
other Slc family members that were up-regulated during
development may also have roles. Immunomodulatory
compounds that inhibit human and rat T lymphocyte
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Page 11 of 16Figure 6 Impact of liver development on xenobiotic metabolism gene expression. A.Canonical pathways involved in xenobiotic
metabolism. Scale is described in Figure 2. B. Expression of Cyp genes. C. Expression of phase II conjugating genes. D. Expression of phase III
transporter genes. Right, detail of up-regulated transporter genes. Arrowheads indicate genes identified as being bone marrow-specific and thus
may originate from extrahepatic cells. E. Expression of nuclear receptors during development including those that regulate xenobiotic
metabolism.
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Page 12 of 16proliferation act by inhibiting Slc16a1 [50]. The essential
role of Slc20a1 in liver development was determined in
Slc20a1-null mice which displayed decreased prolifera-
tion, extensive apoptosis in the liver and embryonic
lethality at GD12.5 [51], the time of earliest expression
changes observed by microarray (Figure 6D, right).
To begin to address the basis for the low level of
expression observed for many xenobiotic metabolism
genes, the expression of transcription factors that are
known to mediate chemical-inducible gene expression
was examined. Many of the nuclear receptors are targets
of chemicals and drugs. A subset of nuclear receptors
exhibited decreased expression compared to PND67 ani-
mals (Figure 6E). The expression of components of the
dioxin receptor (Ahr, Arnt family members) and Nfe2l2,
also known as Nrf2,( Keap1, Maf family members) did
not exhibit changes throughout development. We
hypothesize that the expression of xenobiotic metabo-
lism genes is reduced relative to the adult due to lower
expression of the factors that control their basal tran-
scription levels. One such factor could be the nuclear
receptor Hnf4a which controls the expression of a large
number of liver-specific genes [52]. Like our microarray
results, Li et al. [13] observed an increase in the expres-
sion profile of Hnf4a during mouse liver development,
with enhanced expression occurring at postnatal stages.
Our comprehensive analysis of XME expression adds
to the current body of knowledge which indicates that
development affects the hepatic expression of XMEs in
mice and rats. A comparative expression profiling of 40
mouse cytochrome P450 genes in GD7, GD11, GD15,
and GD17 Swiss Weber/NIH embryos was conducted
using multiple tissue Clontech cDNA panel Mouse I [53].
Twenty-seven P450s were expressed during development
with numbers gradually increasing throughout develop-
ment. Cyp2s1, Cyp8a1, Cyp20, Cyp21a1, Cyp26a1,
Cyp46,a n dCyp51 were detected at all stages. In rats,
there is a 4- and 6- fold increase in CYP content at post-
natal days 7 and 14, respectively, compared with day 1 of
birth [54]. CYP1A1 is expressed during early gestation,
but expression of most of the other CYP enzymes occurs
at or near birth (CYP2B, CYP2C23, CYP3A) or immedi-
ately after birth (CYP2E1) [55]. CYP1A2, CYP2C6,
CYP2C11, CYP2C12, and CYP4A10 are expressed after
the first week of birth[55,57,54,56]. CYP2B1 activity at
PND4 is comparable to levels observed in adult livers
[54], whereas postnatal [55] activity of CYP2E1 increases
linearly with age and at PND30 is comparable to that in
adult liver [55,54]. In humans, total cytochrome P450
content in the fetal liver is between 30% and 60% of that
found in the adult and approaches adult values by 10
years of age [58]. CYP3A7 activity is high immediately
after birth; during the first days after birth there is a shift
from mainly CYP3A7 activity to CYP3A4 activity [59].
CYP2D6 and CYP2E1 activities are minimal in the fetal
liver but quickly increase hours after birth [60,61]. Son-
nier et al. reported delayed ontogenesis of CYP1A2 in the
human liver [62].
In summary, analysis of xenobiotic metabolism genes
indicates that there are profound differences in their
expression compared to the young adult. While there are
a number of genes that exhibit increased expression com-
pared to the adult, the vast majority of genes exhibit
decreased levels. These decreases could potentially result
in prolonged chemical effects including toxicity in the
fetus due to inability to metabolize and excrete xenobio-
tics. Predictions of chemical sensitivities can be made by
identifying chemicals that interact with individual XMEs.
This would include XMEs involved in the metabolism of
a chemical whose expression is decreased during early
life stages. However, depending on the chemical, there
may be cases where decreased expression of a CYP may
be protective of the fetus. For example, CYP1A2 metabo-
lically activates aflatoxin B1 to its carcinogenic metabolite
[63]. Future work will be directed towards determining
the chemicals to which the fetus and the neonate may
exhibit altered responses and will depend in part on
accounting for the effects of tissues that act as a meta-
bolic barrier to environmental exposure to protect the
embryo (yolk sac) and the fetus (placenta).
Conclusions
Our microarray analysis demonstrates that the fetal liver
undergoes dramatic transcriptional changes during
development and maturation. We identified key path-
ways that support the growth and function of the devel-
oping liver. Signature genes for erythropoiesis were
identified and indicate that nucleated erythrocytes exhi-
bit the dominant hematopoietic cell transcriptional sig-
nature in the developing liver. Our results also indicate
that the developing liver exhibits transcriptional features
similar to the adult pancreas, which may reflect the
common embryonic origins of these tissues. The vast
majority of genes associated with xenobiotic metabolism
and transport exhibit decreased expression compared to
the adult which may alter susceptibility to environmen-
tal chemicals in the fetus and neonate. Our analysis also
emphasizes that microarray datasets can be successfully
combined to create a broader view of gene expression
changes during development.
Additional material
Additional file 1: Source bias removal demonstrated with RNA
spike-in controls. 64 Affymetrix hybridization control probesets were
analyzed with principal component analysis before and after the
application of Distance Weighted Discrimination. Red, GD19-PND67
samples from the EPA dataset. Black, GD11.5-16.5 samples from the Otu
et al. [13] dataset.
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Page 13 of 16Additional file 2: Expression of actin and GAPDH during mouse
liver development. RT-PCR of gene expression in livers from GD14 to
PND28.
Additional file 3: Expression changes in fetal liver genes. Genes
which exhibited significant differences (p < 2.55E-08) between fetal liver
and all adult tissues are shown.
Additional file 4: Expression of Makorin 1 and Regulator of
Differentiation 1 by microarray and in situ hybridization. Figure S1:
Expression of the probesets for Mkrn1 and Rod1 through development.
Figures S2-S6: In situ hybridization of Mkrn1 or Rod1 at the indicated
times during development. L, liver; Lu, lung; St, stomach; M,
metanephros; SC, spinal cord; DRG, dorsal root ganglion; LA, atrium; NE,
neuroepithelium of neural tube; MT, mesonephric tubules; UB is ureteric
bud.
Additional file 5: Gene expression changes in the livers of fetal and
neonatal mice. Gene expression changes during development of the
mouse liver (GD11.5, GD12.5, GD13.5, GD16.5, GD19, PND7, PND30).
Additional file 6: Gene expression changes during discrete windows
of development in the livers of fetal and neonatal mice.
Classification of genes altered during mouse liver development (early,
mid, late, sustained).
Additional file 7: Canonical pathways involved in signaling altered
during liver development. Canonical pathway information was
extracted from Ingenuity. The scale numbers are the -log(p-value) and
range from < 10
-7 to not significant (NS). Red, up-regulated pathways;
green, down-regulated pathways; black, no change.
Additional file 8: Pathways involved in liver toxicity are altered
during liver development. Pathways mentioned in the text are
indicated by arrowheads. The scale numbers are the -log(p-value) and
range from < 10
-7 to not significant (NS). Red, up-regulated pathways;
green, down-regulated pathways; black, no change.
Additional file 9: Alterations in purine and pyrimidine metabolism
genes at GD16.5. Figure S7: The KEGG metabolic map of purine
metabolism was extracted from IPA. Figure S8: The KEGG metabolic map
of pyrimidine metabolism was extracted from IPA. Pink diamonds
indicate the genes that exhibited increased abundance.
Additional file 10: Expression of marker genes for hematopoietic
cell types. Marker genes from Chambers et al. [16] were used to query
expression across development for hematopoietic stem cells (HSC) (Left)
and all genes from cell types other than HSC and nucleated erythrocytes
that exhibited changes during development (Right).
List of abbreviations
Ct: cycle threshold; PCR: polymerase chain reaction; XME: xenobiotic
metabolizing enzyme.
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